Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.
Co-morbidities
Rishi Sethi , Pravesh Vishwakarma , Akshyaya Pradhan
Aleksandra Bykova , Maria Serova , Maria Chashkina , et al
Biykem Bozkurt, Muthiah Vaduganathan, , et al
Radcliffe Cardiology, Karen Bell; Special Editor: Greg Guillory
Giulio Balestrieri , Raul Limonta , Enrico Ponti , et al
Harriette Van Spall, Stefan James
Carolyn Lam, Scott Solomon, John JV McMurray, et al
David K Ryan , Debasish Banerjee , Fadi Jouhra
James Burton, Shelley Zieroth, Andrew Frankel et al
Shelley Zieroth, Andrew Frankel, James Burton, et al
Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al
Giulio Balestrieri , Raul Limonta , Enrico Ponti , et al
Biykem Bozkurt, Muthiah Vaduganathan, , et al
About
Media
James Burton, Shelley Zieroth, Andrew Frankel et al
Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al
Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al
Shelley Zieroth, Andrew Frankel, James Burton, et al
Carolyn Lam, Scott Solomon, John JV McMurray, et al
Harriette Van Spall, Javed Butler, Faiez Zannad, et al
Media
Biykem Bozkurt, Muthiah Vaduganathan, , et al
Shelley Zieroth, Andrew Frankel, James Burton, et al
Harriette Van Spall, Javed Butler, Faiez Zannad, et al
Carolyn Lam, Scott Solomon, John JV McMurray, et al
Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al
Articles
Mineralocorticoid Receptor Antagonists in Heart Failure
Published:
12 November 2024
Citation:
Cardiac Failure Review 2024;10:e15.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Views: 218
- Downloads: 19
-
Read time: 19m 41s
GLP-1RA in Different HFpEF Phenotypes
Published:
16 October 2024
Citation:
Cardiac Failure Review 2024;10:e14.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Views: 566
- Downloads: 64
-
Read time: 22m 11s
New Insights on HFpEF Treatment
Published:
03 April 2024
Citation:
Cardiac Failure Review 2024;10:e05.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Views: 9078
- Downloads: 768
-
Read time: 18m 10s
Gaps in Modern Heart Failure and Chronic Kidney Disease Research
Published:
23 August 2023
Citation:
European Cardiology Review 2023;18:e51.
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.
For author reprints, please email rob.barclay@radcliffe-group.com.
- Views: 1710
- Downloads: 113
- Citations: 1
-
Read time: 5m